Recursion Pharmaceuticals, Inc. RXRX
$3.27
▲ +0.00% 24H
About
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company focused on using automation, artificial intelligence, machine learning, and data science to discover novel medicines. Recursion Pharmaceuticals develops a technology-driven drug discovery platform that combines biology, chemistry, engineering, an…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees600
TickerRXRX
Statistics
Market Cap$1.73B
Revenue (TTM)$74.7M
Net Income-$644.8M
Net Margin-863.4%
EPS$-1.44
P/E-2.19
P/S24.30
P/B1.57
EV/EBITDA-2.05
ROE-57.2%
Dividend Yield—
Price$3.27
Data: Twelve Data · Revenue = mcap / P/S